Cell death of gamma interferon-stimulated human fibroblasts upon Toxoplasma gondii infection induces early parasite egress and limits parasite replication

Infection and Immunity

Volumn 81, Issue 12, 2013, Pages 4341-4349

  Niedelman, Wendy ^a   Sprokholt, Joris K ^a,b,c   Clough, Barbara ^d   Frickel, Eva Maria ^d   Saeij, Jeroen P J ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPHAGY PROTEIN 5; CASPASE; GAMMA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN; IRON; PROTEIN RIPK3; TRYPTOPHAN; UNCLASSIFIED DRUG;

ARTICLE; CELL DEATH; CONTROLLED STUDY; FIBROBLAST; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; NONHUMAN; PARASITE CLEARANCE; PRIORITY JOURNAL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

APOPTOSIS; CELLS, CULTURED; FIBROBLASTS; GTP-BINDING PROTEINS; HUMANS; INTERFERON-GAMMA; IRON; MICROTUBULE-ASSOCIATED PROTEINS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; TOXOPLASMA; TOXOPLASMOSIS; TRYPTOPHAN;

EID: 84890195846     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00416-13     Document Type: Article

References (54)

1. Suzuki Y, Orellana MA, Schreiber RD, Remington JS. 1988. Interferongamma: the major mediator of resistance against Toxoplasma gondii. Science 240:516-518.
2. Melo MB, Jensen KD, Saeij JP. 2011. Toxoplasma gondii effectors are master regulators of the inflammatory response. Trends Parasitol. 27:487-495.
3. Hill D, Dubey JP. 2002. Toxoplasma gondii: transmission, diagnosis and prevention. Clin. Microbiol. Infect. 8:634-640.
4. Grigg ME, Ganatra J, Boothroyd JC, Margolis TP. 2001. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J. Infect. Dis. 184:633-639.
5. Gilbert RE, Freeman K, Lago EG, Bahia-Oliveira LM, Tan HK, Wallon M, Buffolano W, Stanford MR, Petersen E, EMSCOT. 2008. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl. Trop. Dis. 2:e277. doi:10.1371/journal.pntd.0000277.
6. Hoffmann S, Batz MB, Morris JG. 2012. Annu. cost of illness and qualityadjusted life year losses in the United States due to 14 food-borne pathogens. J. Food Prot. 75:1292-1302.
7. Andrade RM, Wessendarp M, Gubbels MJ, Striepen B, Subauste CS. 2006. CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes. J. Clin. Invest. 116:2366-2377.
8. Lees MP, Fuller SJ, McLeod R, Boulter NR, Miller CM, Zakrzewski AM, Mui EJ, Witola WH, Coyne JJ, Hargrave AC, Jamieson SE, Blackwell JM, Wiley JS, Smith NC. 2010. P2X7 receptor-mediated killing of an intracellular parasite, Toxoplasma gondii, by human and murine macrophages. J. Immunol. 184:7040-7046.
9. Corrêa G, Marques da Silva C, de Abreu Moreira-Souza AC, Vommaro RC, Coutinho-Silva R. 2010. Activation of the P2X(7) receptor triggers the elimination of Toxoplasma gondii tachyzoites from infected macrophages. Microbes Infect. 12:497-504.
10. Witola WH, Mui E, Hargrave A, Liu S, Hypolite M, Montpetit A, Cavailles P, Bisanz C, Cesbron-Delauw MF, Fournié GJ, McLeod R. 2011. NALP1 influences susceptibility to human congenital toxoplasmosis, proinflammatory cytokine response, and fate of Toxoplasma gondiiinfected monocytic cells. Infect. Immun. 79:756-766.
11. Scharton-Kersten TM, Yap G, Magram J, Sher A. 1997. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185:1261-1273.
12. Murray HW, Teitelbaum RF. 1992. L-Arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J. Infect. Dis. 165:513-517.
13. Yap GS, Sher A. 1999. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii. J. Exp. Med. 189:1083-1092.
14. Martens S, Parvanova I, Zerrahn J, Griffiths G, Schell G, Reichmann G, Howard JC. 2005. Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases. PLoS Pathog. 1:e24. doi:10.1371/journal.ppat.0010024.
15. Bekpen C, Hunn JP, Rohde C, Parvanova I, Guethlein L, Dunn DM, Glowalla E, Leptin M, Howard JC. 2005. The interferon-inducible p47 (IRG) GTPases in vertebrates: loss of the cell autonomous resistance mechanism in the human lineage. Genome Biol. 6:R92.
16. Niedelman W, Gold DA, Rosowski EE, Sprokholt JK, Lim D, Farid Arenas A, Melo MB, Spooner E, Yaffe MB, Saeij JP. 2012. The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response. PLoS Pathog. 8:e1002784. doi:10.1371/journal.ppat.1002784.
17. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. 1991. Induction of indoleamine 2,3-dioxygenase in human cells in vitro. Adv. Exp. Med. Biol. 294:505-509.
18. Gupta SL, Carlin JM, Pyati P, Dai W, Pfefferkorn ER, Murphy MJ. 1994. Antiparasitic and antiproliferative effects of indoleamine 2,3-dioxygenase enzyme expression in human fibroblasts. Infect. Immun. 62: 2277-2284.
19. Pfefferkorn ER. 1984. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad. Sci. U. S. A. 81:908-912.
20. Heseler K, Spekker K, Schmidt SK, MacKenzie CR, Däubener W. 2008. Antimicrobial and immunoregulatory effects mediated by human lung cells: role of IFN-γ-induced tryptophan degradation. FEMS Immunol. Med. Microbiol. 52:273-281.
21. Woodman JP, Dimier IH, Bout DT. 1991. Human endothelial cells are activated by IFN-γ to inhibit Toxoplasma gondii replication: inhibition is due to a different mechanism from that existing in mouse macrophages and human fibroblasts. J. Immunol. 147:2019-2023.
22. Dimier IH, Bout DT. 1997. Inhibition of Toxoplasma gondii replication in IFN-γ-activated human intestinal epithelial cells. Immunol. Cell Biol. 75:511-514.
23. Dimier IH, Bout DT. 1998. Interferon-gamma-activated primary enterocytes inhibit Toxoplasma gondii replication: a role for intracellular iron. Immunology 94:488-495.
24. Byrd TF, Horwitz MA. 1989. Interferon gamma-activated human monocytes downregulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. J. Clin. Invest. 83:1457-1465.
25. Murray HW, Granger AM, Teitelbaum RF. 1991. Gamma interferonactivated human macrophages and Toxoplasma gondii, Chlamydia psittaci, and Leishmania donovani: antimicrobial role of limiting intracellular iron. Infect. Immun. 59:4684-4686.
26. Virreira Winter S, Niedelman W, Jensen KD, Rosowski EE, Julien L, Spooner E, Caradonna K, Burleigh BA, Saeij JP, Ploegh HL, Frickel EM. 2011. Determinants of GBP recruitment to Toxoplasma gondii vacuoles and the parasitic factors that control it. PLoS One 6:e24434. doi:10.1371/journal.pone.0024434.
27. Yamamoto M, Okuyama M, Ma JS, Kimura T, Kamiyama N, Saiga H, Ohshima J, Sasai M, Kayama H, Okamoto T, Huang DC, Soldati-Favre D, Horie K, Takeda J, Takeda K. 2012. A cluster of interferon-γ-inducible p65 GTPases plays a critical role in host defense against Toxoplasma gondii. Immunity 37:302-313.
28. Matsuzawa T, Kim BH, Shenoy AR, Kamitani S, Miyake M, Macmicking JD. 2012. IFN-γ elicits macrophage autophagy via the p38 MAPK signaling pathway. J. Immunol. 189:813-818.
29. Traver MK, Henry SC, Cantillana V, Oliver T, Hunn JP, Howard JC, Beer S, Pfeffer K, Coers J, Taylor GA. 2011. Immunity-related GTPaseM (IRGM) proteins influence the localization of guanylate-binding protein 2 (GBP2) by modulating macroautophagy. J. Biol. Chem. 286:30471-30480.
30. Zhao Z, Fux B, Goodwin M, Dunay IR, Strong D, Miller BC, Cadwell K, Delgado MA, Ponpuak M, Green KG, Schmidt RE, Mizushima N, Deretic V, Sibley LD, Virgin HW. 2008. Autophagosome-independent essential function for the autophagy protein Atg5 in cellular immunity to intracellular pathogens. Cell Host Microbe 4:458-469.
31. Levine B, Yuan J. 2005. Autophagy in cell death: an innocent convict? J. Clin. Invest. 115:2679-2688.
32. Han J, Zhong CQ, Zhang DW. 2011. Programmed necrosis: backup to and competitor with apoptosis in the immune system. Nat. Immunol. 12:1143-1149.
33. Rosowski EE, Lu D, Julien L, Rodda L, Gaiser RA, Jensen KD, Saeij JP. 2011. Strain-specific activation of the NF-κB pathway by GRA15, a novel Toxoplasma gondii dense granule protein. J. Exp. Med. 208:195-212.
34. Boyle JP, Saeij JP, Boothroyd JC. 2007. Toxoplasma gondii: inconsistent dissemination patterns following oral infection in mice. Exp. Parasitol. 116:302-305.
35. Lourido S, Tang K, Sibley LD. 2012. Distinct signaling pathways control Toxoplasma egress and host-cell invasion. EMBO J. 31:4524-4534.
36. Schmidt SK, Müller A, Heseler K, Woite C, Spekker K, MacKenzie CR, Däubener W. 2009. Antimicrobial and immunoregulatory properties of human tryptophan 2,3-dioxygenase. Eur. J. Immunol. 39:2755-2764.
37. Cady SG, Sono M. 1991. 1-Methyl-DL-tryptophan, ß-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and ß-[3-benzo(b) thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase. Arch. Biochem. Biophys. 291:326-333.
38. Gail M, Gross U, Bohne W. 2004. Transferrin receptor induction in Toxoplasma gondii-infected HFF is associated with increased ironresponsive protein 1 activity and is mediated by secreted factors. Parasitol. Res. 94:233-239.
39. Wang Y, Karnataki A, Parsons M, Weiss LM, Orlofsky A. 2010. 3-Methyladenine blocks Toxoplasma gondii division prior to centrosome replication. Mol. Biochem. Parasitol. 173:142-153.
40. Ghosh D, Walton JL, Roepe PD, Sinai AP. 2012. Autophagy is a cell death mechanism in Toxoplasma gondii. Cell Microbiol. 14:589-607.
41. Kim BH, Shenoy AR, Kumar P, Das R, Tiwari S, MacMicking JD. 2011. A family of IFN-γ-inducible 65-kD GTPases protects against bacterial infection. Science 332:717-721.
42. Vestal DJ, Jeyaratnam JA. 2011. The guanylate-binding proteins: emerging insights into the biochemical properties and functions of this family of large interferon-induced guanosine triphosphatase. J. Interferon Cytokine Res. 31:89-97.
43. Tietzel I, El-Haibi C, Carabeo RA. 2009. Human guanylate binding proteins potentiate the anti-chlamydia effects of interferon-gamma. PLoS One 4:e6499. doi:10.1371/journal.pone.0006499.
44. Zhao YO, Khaminets A, Hunn JP, Howard JC. 2009. Disruption of the Toxoplasma gondii parasitophorous vacuole by IFNγ-inducible immunityrelated GTPases (IRG proteins) triggers necrotic cell death. PLoS Pathog. 5:e1000288. doi:10.1371/journal.ppat.1000288.
45. Fink SL, Cookson BT. 2005. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect. Immun. 73:1907-1916.
46. Solini A, Chiozzi P, Morelli A, Fellin R, Di Virgilio F. 1999. Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation, and IL-6 release. J. Cell Sci. 112(Pt 3):297-305.
47. Scaffidi P, Misteli T, Bianchi ME. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191-195.
48. Melzer T, Duffy A, Weiss LM, Halonen SK. 2008. The gamma interferon (IFN-γ)-inducible GTP-binding protein IGTP is necessary for toxoplasma vacuolar disruption and induces parasite egression in IFN-γ-stimulated astrocytes. Infect. Immun. 76:4883-4894.
49. Moudy R, Manning TJ, Beckers CJ. 2001. The loss of cytoplasmic potassium upon host cell breakdown triggers egress of Toxoplasma gondii. J. Biol. Chem. 276:41492-41501.
50. Weiss G. 2002. Iron and immunity: a double-edged sword. Eur. J. Clin. Invest. 32(Suppl 1):70-78.
51. Tomita T, Yamada T, Weiss LM, Orlofsky A. 2009. Externally triggered egress is the major fate of Toxoplasma gondii during acute infection. J. Immunol. 183:6667-6680.
52. Stommel EW, Ely KH, Schwartzman JD, Kasper LH. 1997. Toxoplasma gondii: dithiol-induced Ca2+ flux causes egress of parasites from the parasitophorous vacuole. Exp. Parasitol. 87:88-97.
53. Black MW, Arrizabalaga G, Boothroyd JC. 2000. Ionophore-resistant mutants of Toxoplasma gondii reveal host cell permeabilization as an early event in egress. Mol. Cell. Biol. 20:9399-9408.
54. Persson EK, Agnarson AM, Lambert H, Hitziger N, Yagita H, Chambers BJ, Barragan A, Grandien A. 2007. Death receptor ligation or exposure to perforin trigger rapid egress of the intracellular parasite Toxoplasma gondii. J. Immunol. 179:8357-8365.